Abstract
We develop a simple model for assessing risk of airborne disease transmission that accounts for non-uniform mixing in indoor spaces and is compatible with existing epidemiological models. A database containing 174 high-resolution simulations of airflow in classrooms, lecture halls, and buses is generated and used to quantify the spatial distribution of expiratory droplet nuclei for a wide range of ventilation rates, exposure times, and room configurations. Imperfect mixing due to obstructions, buoyancy, and turbulent dispersion results in concentration fields with significant variance. The spatial non-uniformity is found to be accurately described by a shifted lognormal distribution. A well-mixed mass balance model is used to predict the mean, and the standard deviation is parameterized based on ventilation rate and room geometry. When employed in a dose-response function risk model, infection probability can be estimated considering spatial heterogeneity that contributes to both short- and long-range transmission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the College of Engineering at the University of Michigan. The computing resources and assistance provided by the staff of the Advanced Research Computing at the University of Michigan are greatly appreciated. There is no external funding received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
